The American College of Cardiology (ACC) will begin offering a new Transcatheter Valve Certification to U.S. hospitals in mid-2019, the College announced March 13.
The FDA fast-tracked the approval process for a new generic valsartan product (Diovan) amid an ongoing shortage of the blood pressure and heart failure medication.
Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5.
President Trump’s budget proposal for 2020 would negatively impact almost every institute at the NIH, including trimming the funding for the National Heart, Lung and Blood Institute by about $486 million.
A napping habit could lower blood pressure to a similar extent as other lifestyle modifications and some drugs, according to research scheduled to be presented March 18 at the American College of Cardiology’s scientific sessions in New Orleans.
The SPRINT trial suggested a more aggressive blood pressure-lowering target reduced the rate of cardiovascular events in hypertensive people, but a new secondary analysis of the trial indicates such an approach may actually be harmful for smokers.
Edwards Lifesciences has invested $35 million for an exclusive right to acquire Corvia Medical, which is engaged in a U.S. pivotal trial for its InterAtrial Shunt Device (IASD) to treat heart failure.
As people around the country struggle to catch up on sleep after “springing forward” an hour, a Washington Post story reminds us of the health risks associated with adjusting our clocks, including an increased incidence of heart attacks.
President Trump’s proposed “Budget for a Better America” for 2020 would cut Medicare spending by approximately $845 billion and Medicaid spending by approximately $241 billion over 10 years.
Radiologists commonly overlook potentially important information about a patient’s heart health when they’re performing mammograms or CT scans before starting cancer treatment, according to research set to be presented at the American College of Cardiology’s scientific sessions March 16-18 in New Orleans.